National Growth Fund approves 20 billion won ADC loan for Kyongbo Pharmaceutical
AI Summary- National Growth Fund approved Kyongbo Pharmaceutical’s 20 billion Korean won ADC facility loan.
- 20 billion Korean won was approved through the Advanced Strategic Industry Fund.
- Kyongbo plans GMP facility completion by year-end and clinical sample production afterward.